Michael Gibertini, PhD
- 2Articles
- 6.7KReads1
- 2003–2009Active
- 11Collaborators
- 114Citations2
About
Michael Gibertini, PhD, has published research on the treatment of major depressive disorder, focusing on the efficacy and tolerability of pharmacological agents such as vilazodone and gepirone extended-release. His work, appearing between 2003 and 2009 in Psychiatrist.com, includes randomized, double-blind, placebo-controlled trials examining these antidepressant therapies. Gibertini has frequently collaborated with co-authors including Alan D. Feiger, Carol R. Reed, Donald S. Robinson, Heidi Whalen, and J. M. A. Sitsen.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
